- Home
- RVPH vs CISO Comparison
RVPH vs CISO Comparison
Compare RVPH & CISO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- CISO
- Stock Information
- Founded
- RVPH 2006
- CISO 2015
- Country
- RVPH United States
- CISO United States
- Employees
- RVPH N/A
- CISO N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- CISO Computer Software: Prepackaged Software
- Sector
- RVPH Health Care
- CISO Technology
- Exchange
- RVPH Nasdaq
- CISO Nasdaq
- Market Cap
- RVPH 32.8M
- CISO 31.4M
- IPO Year
- RVPH N/A
- CISO N/A
- Fundamental
- Price
- RVPH $0.39
- CISO $1.17
- Analyst Decision
- RVPH Strong Buy
- CISO
- Analyst Count
- RVPH 5
- CISO 0
- Target Price
- RVPH $9.00
- CISO N/A
- AVG Volume (30 Days)
- RVPH 3.0M
- CISO 920.3K
- Earning Date
- RVPH 08-13-2025
- CISO 08-13-2025
- Dividend Yield
- RVPH N/A
- CISO N/A
- EPS Growth
- RVPH N/A
- CISO N/A
- EPS
- RVPH N/A
- CISO N/A
- Revenue
- RVPH N/A
- CISO $29,887,603.00
- Revenue This Year
- RVPH N/A
- CISO N/A
- Revenue Next Year
- RVPH N/A
- CISO N/A
- P/E Ratio
- RVPH N/A
- CISO N/A
- Revenue Growth
- RVPH N/A
- CISO N/A
- 52 Week Low
- RVPH $0.30
- CISO $0.26
- 52 Week High
- RVPH $4.28
- CISO $3.84
- Technical
- Relative Strength Index (RSI)
- RVPH 33.75
- CISO 49.67
- Support Level
- RVPH $0.35
- CISO $1.16
- Resistance Level
- RVPH $0.83
- CISO $1.24
- Average True Range (ATR)
- RVPH 0.06
- CISO 0.11
- MACD
- RVPH -0.02
- CISO -0.01
- Stochastic Oscillator
- RVPH 17.98
- CISO 17.74
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.